biotech · Non-muscle Invasive Bladder Cancer · Intestinal Failure · TARA
Protara Therapeutics
Protara Therapeutics trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.
New York, USA HQ
2017 Founded
56 Employees
Public company Type
TARA · NYSE Ticker
Company details
- Status
- Public
- HQ
- New York, USA
- Founded
- 2017
- Employees
- 56
- Programs
- 7
- Drugs
- 10
- Patents
- 2
Protara Therapeutics clinical trials
Registry index of 9 ClinicalTrials.gov studies linked to Protara Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Protara Therapeutics trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Protara Therapeutics.
-
TARA-001-301 — Phase 3
Clinical update -
Subcutaneous depot medroxyprogesterone acetate — Approved
Clinical update -
Daunorubicin — Phase 1
Clinical update -
Choline Chloride for Injection — Phase 3
Clinical update -
TARA-002 — Phase 2
Clinical update -
TARA-002 — Phase 3
Clinical update -
TARA-002 — Phase 2
Clinical update